✨
AI Summary
- Dr. Naji Gehchan discusses Kyverna Therapeutics' CAR T for autoimmune diseases.
- Miv-cel shows promise in Phase 2 for stiff person syndrome.
- Goal is drug-free remission by depleting pathogenic B cells.
Guests on This Episode
NG
Naji Gehchan
1 podcast appearance